• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长链非编码RNA PEG10通过调控HOXA9加重心肌肥大。

LncRNA PEG10 aggravates cardiac hypertrophy through regulating HOXA9.

作者信息

Wen Z-Q, Li S-H, Shui X, Tang L-L, Zheng J-R, Chen L

机构信息

Department of Cardiovascular Medicine, the Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.

出版信息

Eur Rev Med Pharmacol Sci. 2019 Aug;23(3 Suppl):281-286. doi: 10.26355/eurrev_201908_18658.

DOI:10.26355/eurrev_201908_18658
PMID:31389601
Abstract

OBJECTIVE

To uncover the role of long non-coding RNA (lncRNA) PEG10 in the progression of cardiac hypertrophy by regulating HOXA9.

MATERIALS AND METHODS

In vivo cardiac hypertrophy model was established by performing transverse aortic constriction model (TAC) procedures in mice. Relative levels of PEG10, ANP and BNP in mice undergoing TAC procedures or sham operations were determined. In vitro cardiac hypertrophy model was established by phenylephrine (PE) treatment in primary cardiomyocytes. Relative levels of PEG10, ANP and BNP in cardiomyocytes were determined as well. Regulatory effects of HOXA9 on surface area of cardiomyocytes and relative levels of ANP and BNP were assessed. Finally, potential influences of PEG10/HOXA9 regulatory loop on cell surface area and relative levels of ANP and BNP were explored.

RESULTS

Compared with mice in sham group, those in TAC group presented higher levels of PEG10, ANP and BNP. PE treatment markedly upregulated PEG10, ANP and BNP in primary cardiomyocytes, which were downregulated by transfection of si-PEG10. Besides, surface area of cardiomyocytes was enlarged by PE treatment, which was reduced after silence of PEG10. Silence of HOXA9 presented a similar effect as that of PEG10 in cardiomyocytes. Transfection of si-HOXA9 reversed the expanded cell surface area, and upregulated ANP and BNP in cardiomyocytes overexpressing PEG10.

CONCLUSIONS

PEG10 is upregulated in hypertrophic cardiomyocytes. PEG10 aggravates cardiac hypertrophy by positively regulating HOXA9.

摘要

目的

通过调控HOXA9揭示长链非编码RNA(lncRNA)PEG10在心肌肥厚进展中的作用。

材料与方法

通过对小鼠进行主动脉缩窄模型(TAC)建立体内心肌肥厚模型。测定接受TAC手术或假手术的小鼠中PEG10、心钠素(ANP)和脑钠肽(BNP)的相对水平。通过用去甲肾上腺素(PE)处理原代心肌细胞建立体外心肌肥厚模型。同时测定心肌细胞中PEG10、ANP和BNP的相对水平。评估HOXA9对心肌细胞表面积以及ANP和BNP相对水平的调节作用。最后,探究PEG10/HOXA9调控环对细胞表面积以及ANP和BNP相对水平的潜在影响。

结果

与假手术组小鼠相比,TAC组小鼠的PEG10、ANP和BNP水平更高。PE处理显著上调原代心肌细胞中的PEG10、ANP和BNP,而转染si-PEG10可使其下调。此外,PE处理使心肌细胞表面积增大,沉默PEG10后表面积减小。沉默HOXA9在心肌细胞中呈现出与PEG10类似的效果。转染si-HOXA9可逆转过表达PEG10的心肌细胞中扩大的细胞表面积,并上调ANP和BNP。

结论

PEG10在肥厚型心肌细胞中上调。PEG10通过正向调控HOXA9加重心肌肥厚。

相似文献

1
LncRNA PEG10 aggravates cardiac hypertrophy through regulating HOXA9.长链非编码RNA PEG10通过调控HOXA9加重心肌肥大。
Eur Rev Med Pharmacol Sci. 2019 Aug;23(3 Suppl):281-286. doi: 10.26355/eurrev_201908_18658.
2
lncRNA UCA1 Is a Novel Regulator in Cardiomyocyte Hypertrophy through Targeting the miR-184/HOXA9 Axis.长链非编码 RNA UCA1 通过靶向 miR-184/HOXA9 轴成为心肌细胞肥大的新型调控因子。
Cardiorenal Med. 2018;8(2):130-139. doi: 10.1159/000487204. Epub 2018 Mar 20.
3
lncRNA ZEB2-AS1 stimulates cardiac hypertrophy by downregulating PTEN.长链非编码RNA ZEB2-AS1通过下调PTEN来刺激心肌肥大。
Exp Ther Med. 2020 Nov;20(5):92. doi: 10.3892/etm.2020.9220. Epub 2020 Sep 16.
4
Cardiac hypertrophy is positively regulated by long non-coding RNA PVT1.心脏肥大受长链非编码RNA PVT1的正向调控。
Int J Clin Exp Pathol. 2015 Mar 1;8(3):2582-9. eCollection 2015.
5
Qiliqiangxin Attenuates Phenylephrine-Induced Cardiac Hypertrophy through Downregulation of MiR-199a-5p.芪苈强心通过下调miR-199a-5p减轻去甲肾上腺素诱导的心肌肥厚。
Cell Physiol Biochem. 2016;38(5):1743-51. doi: 10.1159/000443113. Epub 2016 May 9.
6
GDF11 Attenuated ANG II-Induced Hypertrophic Cardiomyopathy and Expression of ANP, BNP and Beta-MHC Through Down- Regulating CCL11 in Mice.GDF11 通过下调 CCL11 减轻血管紧张素 II 诱导的肥厚性心肌病和 ANP、BNP 及β-MHC 的表达。
Curr Mol Med. 2018;18(10):661-671. doi: 10.2174/1566524019666190204112753.
7
Long Non-Coding RNA-ROR Mediates the Reprogramming in Cardiac Hypertrophy.长链非编码RNA-ROR介导心肌肥厚中的重编程。
PLoS One. 2016 Apr 15;11(4):e0152767. doi: 10.1371/journal.pone.0152767. eCollection 2016.
8
SP1-induced SNHG14 aggravates hypertrophic response in in vitro model of cardiac hypertrophy via up-regulation of PCDH17.SP1 诱导的 SNHG14 通过上调 PCDH17 加重体外心肌肥厚模型中的肥厚反应。
J Cell Mol Med. 2020 Jul;24(13):7115-7126. doi: 10.1111/jcmm.15073. Epub 2020 May 21.
9
LincRNA RMRP Regulates Phenylephrine-induced Cardiomyocyte Hypertrophy by Means of Targeting miR-1.长链非编码 RNA RMRP 通过靶向 miR-1 调控苯肾上腺素诱导的心肌细胞肥大。
J Cardiovasc Pharmacol. 2022 Nov 1;80(5):709-717. doi: 10.1097/FJC.0000000000001366.
10
STAT3-induced upregulation of lncRNA MEG3 regulates the growth of cardiac hypertrophy through miR-361-5p/HDAC9 axis.STAT3 诱导的长链非编码 RNA MEG3 通过 miR-361-5p/HDAC9 轴调节心肌肥厚的生长。
Sci Rep. 2019 Jan 24;9(1):460. doi: 10.1038/s41598-018-36369-1.

引用本文的文献

1
LncRNA CCAT2 Knockdown Alleviates Pressure Overload or Ang II-Induced Cardiac Hypertrophy Via Disruption of the Wnt/β-Catenin Signaling.长链非编码 RNA CCAT2 敲低通过破坏 Wnt/β-连环蛋白信号减轻压力超负荷或 Ang II 诱导的心肌肥厚。
Arq Bras Cardiol. 2024 Oct;121(10):e20240181. doi: 10.36660/abc.20240181.
2
Posttranscriptional Regulation by Proteins and Noncoding RNAs.蛋白质和非编码 RNA 的转录后调控。
Adv Exp Med Biol. 2024;1441:313-339. doi: 10.1007/978-3-031-44087-8_17.
3
Study on Potential Differentially Expressed Genes in Idiopathic Pulmonary Fibrosis by Bioinformatics and Next-Generation Sequencing Data Analysis.
基于生物信息学和二代测序数据分析的特发性肺纤维化潜在差异表达基因研究
Biomedicines. 2023 Nov 21;11(12):3109. doi: 10.3390/biomedicines11123109.
4
Deciphering the emerging landscape of HOX genes in cardiovascular biology, atherosclerosis and beyond (Review).解析 HOX 基因在心血管生物学、动脉粥样硬化及其他领域中的新兴作用(综述)。
Int J Mol Med. 2024 Feb;53(2). doi: 10.3892/ijmm.2023.5341. Epub 2023 Dec 22.
5
SLC26A4-AS1 Aggravates AngII-induced Cardiac Hypertrophy by Enhancing SLC26A4 Expression.SLC26A4-AS1 通过增强 SLC26A4 的表达加剧 AngII 诱导的心肌肥厚。
Arq Bras Cardiol. 2023 Apr 21;120(4):e20210933. doi: 10.36660/abc.20210933. eCollection 2023.
6
Role of HOXA9 in solid tumors: mechanistic insights and therapeutic potential.HOXA9在实体瘤中的作用:机制洞察与治疗潜力
Cancer Cell Int. 2022 Nov 14;22(1):349. doi: 10.1186/s12935-022-02767-9.
7
Noncoding RNAs in Cardiac Hypertrophy and Heart Failure.非编码 RNA 在心肌肥厚和心力衰竭中的作用。
Cells. 2022 Feb 23;11(5):777. doi: 10.3390/cells11050777.
8
Long noncoding RNA H19 suppresses cardiac hypertrophy through the MicroRNA-145-3p/SMAD4 axis.长链非编码 RNA H19 通过 MicroRNA-145-3p/SMAD4 轴抑制心肌肥厚。
Bioengineered. 2022 Feb;13(2):3826-3839. doi: 10.1080/21655979.2021.2017564.
9
The prognostic value of homeobox A9 (HOXA9) methylation in solid tumors: a systematic review and meta-analysis.同源盒A9(HOXA9)甲基化在实体瘤中的预后价值:一项系统评价和荟萃分析
Transl Cancer Res. 2021 Oct;10(10):4347-4354. doi: 10.21037/tcr-21-765.
10
Reconnoitering the Role of Long-Noncoding RNAs in Hypertrophic Cardiomyopathy: A Descriptive Review.长链非编码 RNA 在肥厚型心肌病中的作用研究:描述性综述。
Int J Mol Sci. 2021 Aug 29;22(17):9378. doi: 10.3390/ijms22179378.